Wednesday 30 January 2013

Sanofi expects FDA decision on Lemtrada in H2

PARIS (Reuters) - Sanofi expects the U.S. Food and Drug Administration to rule on its application for multiple sclerosis treatment Lemtrada by the second half of this year. The injectable drug, chemically known as alemtuzumab, is one of the new pr...

Source: http://health.yahoo.net/news/s/nm/sanofi-expects-fda-decision-on-lemtrada-in-h2

Troy Davis Eugene Murphy Jr. Libya Pia Toscano

No comments:

Post a Comment

Note: only a member of this blog may post a comment.